Modeling and simulation guides dosing for a new anti-psychotic drug
Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…
Certara2016 年 10 月 21 日
Rare Disease and Orphan Drug Development
There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…
Certara2016 年 8 月 3 日
Model-based Meta-analysis: An Innovative Methodology Comes of Age
MBMA integrates internal and external drug development data to inform proprietary commercial and R&D decisions.…
Certara2016 年 7 月 14 日
How Does the In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology Approach
Information on the developmental changes in biliary excretion (BE) of drugs is sparse. The aims…
Certara2016 年 7 月 1 日
